Related Articles
Glucose transporter‑1 inhibition overcomes imatinib resistance in gastrointestinal stromal tumor cells
Establishment of a GIST-T1 gastrointestinal stromal tumour cell line resistant to imatinib mesylate
Improved understanding of gastrointestinal stromal tumors biology as a step for developing new diagnostic and therapeutic schemes (Review)
Expression of stem cell factor in gastrointestinal stromal tumors: Implications for proliferation and imatinib resistance
Effects of imatinib vary with the types of KIT-mutation in gastrointestinal stromal tumor cell lines